2,2,4,4-tetramethyl-valeric acid amide | 32905-64-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2,2,4,4-tetramethyl-valeric acid amide
• 英文别名: 2,2,4,4-Tetramethyl-valeriansaeure-amid；2,2,4,4-Tetramethylpentansaeureamid；2.2.4.4-Tetramethylpentansaeureamid；2,2,4,4-Tetramethylvaleramide；2,2,4,4-tetramethylpentanamide
• CAS: 32905-64-9
• 化学式: C₉H₁₉NO
• 分子量: 157.256
• InChiKey: AGCBBXPWJMYJGB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2,2,4,4-tetramethyl-valeric acid amide 在 lithium aluminium tetrahydride 、 phosphorus pentoxide 作用下， 以 乙醚 为溶剂， 生成 2.2.4.4-Tetramethyl-pentylamin
  参考文献：
  名称：

  Lespagnol,A. et al., Chimica Therapeutica, 1971, vol. 6, p. 208 - 214

  摘要：

  DOI：
• 作为产物：
  描述：

  2,2,4,4-四甲基戊酸 在 氯化亚砜 作用下， 生成 2,2,4,4-tetramethyl-valeric acid amide
  参考文献：
  名称：

  New Compounds. Dimethylneopentylacetic Acid (2,2,4,4-Tetramethylpentanoic Acid), itsethyl Ester, Amide and Acetanilide

  摘要：

  DOI：

  10.1021/ja01856a601

文献信息

• [EN] CNP PRODRUGS WITH CARRIER ATTACHMENT AT THE RING MOIETY<br/>[FR] PROMÉDICAMENTS DE CNP AVEC FIXATION D'UN SUPPORT SUR LA PARTIE CYCLIQUE
  申请人：ASCENDIS PHARMA GROWTH DISORDERS AS

  公开号：WO2017118698A1

  公开（公告）日：2017-07-13

  The present invention relates to CNP prodrugs in which the carrier is covalently and reversibly attached to the ring moiety of a CNP moiety, to pharmaceutical compositions comprising such CNP prodrugs, to their uses and to methods of treating diseases that can be treated with the CNP prodrugs of the present invention.

  本发明涉及一种CNP前药，其中载体以共价和可逆地连接到CNP基团的环基团上，涉及包含这种CNP前药的药物组合物，涉及它们的用途以及用于治疗可以用本发明的CNP前药治疗的疾病的方法。
• STILBENE-BASED COMPOUND OR SALT THEREOF, AND POLARIZING FILM, POLARIZING PLATE, AND DISPLAY DEVICE
  申请人：NIPPON KAYAKU KABUSHIKI KAISHA

  公开号：US20200157353A1

  公开（公告）日：2020-05-21

  The present disclosure is a stilbene-based compound or a salt thereof represented by a following formula (1), wherein a group X represents a nitro group or an amino group optionally having a substituent; a group Y represents an amide group optionally having a substituent or a naphthotriazole group optionally having a substituent; and p and q each independently represent an integer of 0 to 2.

  本公开涉及一种基于stilbene的化合物或其盐，其表示如下式（1），其中X代表一个硝基或一个氨基，可选地具有取代基；Y代表一个酰胺基，可选地具有取代基，或一个萘三唑基，可选地具有取代基；p和q各自独立地代表0到2的整数。
• Catalyst system for polymerisation of an olefin
  申请人：Saudi Basic Industries Corporation

  公开号：EP2837634A1

  公开（公告）日：2015-02-18

  The present invention relates to a catalyst system comprising a procatalyst, a co-catalyst and an external electron donor, wherein the external electron donor comprises a compound having the structure according to Formula I:         Si (L)n (OR1)4-n     (Formula I), wherein, Si is a silicon atom with valency 4+; O is an oxygen atom with valency 2- and O is bonded to Si via the silicon-oxygen bond; n is 1, 2, 3 or 4; R1 is a selected from the group consisting of linear, branched and cyclic alkyl having at most 20 carbon atoms and aromatic substituted and unsubstituted hydrocarbyl having 6 to 20 carbon atoms; L is a group represented by Formula II wherein, L is bonded to the silicon atom via the nitrogen-silicon bond; L has a single substituent on the nitrogen atom, where this single substituent is an imine carbon atom; and X and Y are independently selected from the group consisting of a hydrogen atom; a heteroatom selected from group 13, 14, 15, 16 or 17 of the IUPAC Periodic Table of the Elements; a linear, branched and cyclic alkyl having at most 20 carbon atoms, optionally containing a heteroatom selected from group 13, 14, 15, 16 or 17 of the IUPAC Periodic Table of the Elements and an aromatic substituted and unsubstituted hydrocarbyl having 6 to 20 carbon atoms, optionally containing a heteroatom selected from group 13, 14, 15, 16 or 17 of the IUPAC Periodic Table of the Elements.

  本发明涉及一种催化剂体系，包括前催化剂、共催化剂和外部电子给体，其中所述外部电子给体包括具有以下结构的化合物，其符号如下：         Si(L)n(OR1)4-n     （式I） 其中， Si是一个价态为4+的硅原子； O是一个价态为2-的氧原子，并且O通过硅氧键与Si相连； n为1、2、3或4； R1选择自线性、支链和环烷基，其最多有20个碳原子，以及含有6至20个碳原子的芳香基取代和未取代的碳氢基； L是由以下式子表示的一个基团，其中， L通过氮硅键与硅原子相连； L在氮原子上有一个单取代基团，其中这个单取代基团是一个亚胺碳原子； X和Y独立地选择自氢原子；IUPAC元素周期表的13、14、15、16或17族中的杂原子；最多有20个碳原子的线性、支链和环烷基，可选地含有IUPAC元素周期表的13、14、15、16或17族中的杂原子；以及含有6至20个碳原子的芳香基取代和未取代的碳氢基，可选地含有IUPAC元素周期表的13、14、15、16或17族中的杂原子。
• [EN] CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN<br/>[FR] SYSTÈME CATALYSEUR POUR LA POLYMÉRISATION D'UNE OLÉFINE
  申请人：SAUDI BASIC IND CORP

  公开号：WO2015022298A1

  公开（公告）日：2015-02-19

  The present invention relates to a catalyst system comprising a procatalyst, a co-catalyst and an external electron donor, wherein the external electron donor comprises a compound having the structure according to Formula I: Si (L)n (OR11)4-n (Formula I), wherein, Si is a silicon atom with valency 4+; O is an oxygen atom with valency 2- and O is bonded to Si via the silicon-oxygen bond; n is 1, 2, 3 or 4; R11 is a selected from the group consisting of linear, branched and cyclic alkyl having at most 20 carbon atoms and aromatic substituted and unsubstituted hydrocarbyl having 6 to 20 carbon atoms; L is a group represented by (Formula II), wherein, L is bonded to the silicon atom via the nitrogen-silicon bond; L has a single substituent on the nitrogen atom, where this single substituent is an imine carbon atom; and X and Y are independently selected from the group consisting of a hydrogen atom; a heteroatom selected from group 13, 14, 15, 16 or 17 of the IUPAC Periodic Table of the Elements; a linear, branched and cyclic alkyl having at most 20 carbon atoms, optionally containing a heteroatom selected from group 13, 14, 15, 16 or 17 of the IUPAC Periodic Table of the Elements and an aromatic substituted and unsubstituted hydrocarbyl having 6 to 20 carbon atoms, optionally containing a heteroatom selected from group 13, 14, 15, 16 or 7 of the IUPAC Periodic Table of the Elements.

  本发明涉及一种催化剂体系，包括原催化剂、协同催化剂和外部电子供体，其中外部电子供体包括具有以下结构的化合物：Si（L）n（OR11）4-n（式I），其中，Si是具有4价的硅原子；O是具有2价的氧原子，通过硅氧键与Si相连；n为1、2、3或4；R11选自具有最多20个碳原子的线性、支链和环烷基以及具有6至20个碳原子的芳香族取代和未取代的烃基；L是由（式II）表示的一组，其中，L通过氮硅键与硅原子相连；L在氮原子上具有单个取代基，该单个取代基为亚胺碳原子；X和Y分别选自IUPAC元素周期表的13、14、15、16或17族的杂原子、最多含有20个碳原子的线性、支链和环烷基，可以包含来自IUPAC元素周期表的13、14、15、16或17族的杂原子，以及具有6至20个碳原子的芳香族取代和未取代的烃基，可以包含来自IUPAC元素周期表的13、14、15、16或17族的杂原子。
• Melanocortin Receptor-Specific Peptides
  申请人：AstraZeneca AB

  公开号：US20150252077A1

  公开（公告）日：2015-09-10

  The invention relates to melanocortin receptor-specific cyclic peptides of Formula (I) or a pharmaceutically acceptable salt thereof, where R 1 , R 2 , R 3 , R 4a , R 4b , R 4c , R 5 , x and y are as defined in the specification. These compounds are particularly useful in the treatments of energy homeostasis and metabolism related (e.g. diabetes), food intake related and/or energy balance and body weight related diseases, disorders and/or conditions, including obesity, overweight and diseases, disorders and/or conditions associated with obesity and/or overweight, such as type 2 diabetes and metabolic syndrome.

  本发明涉及公式（I）的黑素皮质素受体特异性环肽或其药学上可接受的盐，其中R1、R2、R3、R4a、R4b、R4c、R5、x和y如规范中所定义。这些化合物在能量稳态和代谢相关（例如糖尿病）、食物摄入相关和/或能量平衡和体重相关的疾病、疾病和/或状况，包括肥胖、超重以及与肥胖和/或超重相关的疾病、疾病和/或状况的治疗中特别有用，例如2型糖尿病和代谢综合征。